Nav: Home

TSRI researchers identify gene responsible for mesenchymal stem cells' stem-ness'

January 22, 2018

JUPITER, FL - Jan. 22, 2018 - Many doctors, researchers and patients are eager to take advantage of the promise of stem cell therapies to heal damaged tissues and replace dysfunctional cells. Hundreds of ongoing clinical trials are currently delivering these therapies to patients worldwide.

Mesenchymal stem cells (MSCs) are popular tools for these therapies because they can differentiate into a variety of mature cell types such as bone, fat and cartilage. They also support hematopoiesis--the formation of blood cells--and secrete beneficial factors that promote tissue repair. Unfortunately, scientists often struggle to predict how these cells will act in different environments in the body.

Researchers on the Florida campus of The Scripps Research Institute (TSRI) recently published a study in the journal Cell Death and Differentiation identifying factors crucial to MSC differentiation, providing insight into how these cells should be studied for clinical purposes.

Primary MSCs from bone marrow are delicate, and it´s difficult to keep them alive in a petri dish. For this reason, most scientists studying them use cell lines, cells that have been altered to live and replicate indefinitely. To create immortal MSC lines, scientists delete a gene called p53 required for the cells to undergo normal, programmed cell death, called apoptosis. The new study, conducted by researchers in the lab of TSRI Professor Donald Phinney, PhD, shows that the gene influences far more than just apoptosis; it is also a master regulator of the cells' ability to differentiate.

"Many publications have used immortalized cells as MSC surrogates, but they may not mean much if they don't have functionally accurate p53," says Siddaraju Boregowda, PhD, a TSRI research associate and one of the study's two lead authors.

The researchers compared cells cultured from mice that did not express the p53 gene with cells that came from normal mice. They found that the level of active p53 was the master regulatory factor in determining how MSCs grow and differentiate. The study explains that the gene exerts its effects through its interactions with reactive oxygen species as well as two transcription factors: TWIST2 and PPARG.

When the researchers deleted p53 completely, the cells became immortal but quickly developed into bone. They lost their ability to promote hematopoiesis or become other types of cells, like fat. A low level of p53 induced TWIST2, which kept the MSCs in a stem state, rather than promoting any differentiation. A slightly higher level of p53 induced PPARG and reactive oxygen species, which led the cells to differentiate into fat cells, but not bone. At even higher levels of p53, the cells died.

A basal level of p53 in cells in the culture is required for them to act as an accurate model for cells in the body, explains Veena Krishnappa, PhD, the study's other lead author, previously a postdoctoral researcher in Phinney's lab.

In addition to suggesting that the dramatic effects of deleting p53 may make MSC cell lines an inappropriate surrogate to predict the cells' behavior in clinical applications, the study also suggests that inactivation of p53 may play multiple roles in the progression of bone cancers.

"P53 inactivation not only promotes sustained growth but also makes the cells insensitive to oxidative stress and short-circuits pathways that constrain cellular differentiation. Each of these changes likely contribute significantly to tumorigenesis and tumor progression," says Phinney. "Continuing to delineate the important role of MSCs in skeletal disease may open the door to devising new therapeutic interventions."
-end-
In addition to Boregowda, Krishnappa and Phinney, authors of the study, "Basal p53 expression is indispensable for mesenchymal stem cell integrity," include Jacqueline Strivelli, Christopher L. Haga and Cori N. Booker of The Scripps Research Institute.

This work was supported by funding from the National Institutes of Health (grant R24 OD18254).

Cover photo courtesy National Institutes of Health, Chun Yang, Hao Ma and Anouk Killaars, University of Colorado Boulder

About The Scripps Research Institute

The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs more than 2,500 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists--including two Nobel laureates and 20 members of the National Academies of Science, Engineering or Medicine--work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. In October 2016, TSRI announced a strategic affiliation with the California Institute for Biomedical Research (Calibr), representing a renewed commitment to the discovery and development of new medicines to address unmet medical needs. For more information, see http://www.scripps.edu.

Scripps Research Institute

Related Fat Articles:

Replacing saturated fat with healthier fat may lower cholesterol as well as drugs
Scientific studies that lowered intake of saturated fat and replaced it with polyunsaturated vegetable oil reduced cardiovascular disease by approximately 30 percent; similar to cholesterol-lowering drugs, known as statins.
Can fat 'feel' fat?
Researchers at the University of Iowa have discovered that a molecule which can sense the swelling of fat cells also controls a signaling pathway that allows fat cells to take up and store excess glucose.
Imaging from UK biobank participants shows that people with higher internal organ fat and thigh muscle fat spend more nights in hospital
New research presented at this year's European Congress on Obesity (ECO) in Porto, Portugal (May 17-20) shows that middle-aged people who spend the most nights in hospital (and thus have the highest healthcare burden) have on average much higher levels of visceral fat (internal fat that surrounds their organs) and fat within their thigh muscles than those who spend no nights in hospital.
Breast cancer risk is more affected by total body fat than abdominal fat
A reduction in overall body fat, rather than abdominal fat, is associated with lower levels of breast cancer markers.
Low-calorie sweeteners promote fat accumulation in human fat
Low-calorie, artificial sweeteners appear to play havoc with the body's metabolism, and large consumption of these sugar substitutes could promote fat accumulation, especially in people who are already obese, preliminary research suggests.
Making metabolically active brown fat from white fat-derived stem cells
Researchers have demonstrated the potential to engineer brown adipose tissue, which has therapeutic promise to treat metabolic diseases such as obesity and type 2 diabetes, from white adipose-derived stem cells (ASCs).
Saturated fat could be good for you
A Norwegian study shows that saturated fat actually could be good for you.
New molecule may help fight obesity by converting 'bad' fat to 'good' fat
New research, published online in The FASEB Journal, suggests that activation of a chemical called β-LGND2 by the estrogen receptor β (ER- β) reduces obesity and metabolic diseases in mice by converting bad fat (white fat) to good fat (brown fat).
Scientists work to stop fat cells from becoming large, dysfunctional on a high-fat diet
A high-fat diet makes your fat cells larger, inflamed and dysfunctional, putting you at increased risk for diabetes and cardiovascular disease.
Tasty fat: X-rays finding the blueprint of why fat is yummy
Over three years, a University of Guelph team has brought increasingly complex samples of edible fat to the APS for research.

Related Fat Reading:

Salt, Fat, Acid, Heat: Mastering the Elements of Good Cooking
by Samin Nosrat (Author), Wendy MacNaughton (Illustrator)

Fat: An Appreciation of a Misunderstood Ingredient, with Recipes
by Jennifer McLagan (Author), Leigh Beisch (Photographer)

The Big Fat Surprise: Why Butter, Meat and Cheese Belong in a Healthy Diet
by Nina Teicholz (Author)

The Secret Life of Fat: The Science Behind the Body's Least Understood Organ and What It Means for You
by Sylvia Tara PhD (Author)

Fat for Fuel: A Revolutionary Diet to Combat Cancer, Boost Brain Power, and Increase Your Energy
by Dr. Joseph Mercola (Author)

Everything You Need to Ace Math in One Big Fat Notebook: The Complete Middle School Study Guide (Big Fat Notebooks)
by Workman Publishing (Author), Altair Peterson (Author), Ouida Newton (Editor), Editors of Brain Quest (Editor)

Why We Get Fat: And What to Do About It
by Random House Audio

Everything You Need to Ace English Language Arts in One Big Fat Notebook: The Complete Middle School Study Guide (Big Fat Notebooks)
by Workman Publishing (Author), Jen Haberling (Editor), Editors of Brain Quest (Editor)

Everything You Need to Ace Science in One Big Fat Notebook: The Complete Middle School Study Guide (Big Fat Notebooks)
by Workman Publishing (Author), Sharon Madanes (Author), Michael Geisen (Editor), Editors of Brain Quest (Editor)

Eat Fat, Get Thin: Why the Fat We Eat Is the Key to Sustained Weight Loss and Vibrant Health
by Mark Hyman M.D. (Author)

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Approaching With Kindness
We often forget to say the words "thank you." But can those two words change how you — and those around you — look at the world? This hour, TED speakers on the power of gratitude and appreciation. Guests include author AJ Jacobs, author and former baseball player Mike Robbins, Dr. Laura Trice, Professor of Management Christine Porath, and former Danish politician Özlem Cekic.
Now Playing: Science for the People

#509 Anisogamy: The Beginning of Male and Female
This week we discuss how the sperm and egg came to be, and how a difference of reproductive interest has led to sexual conflict in bed bugs. We'll be speaking with Dr. Geoff Parker, an evolutionary biologist credited with developing a theory to explain the evolution of two sexes, about anisogamy, sexual reproduction through the fusion of two different gametes: the egg and the sperm. Then we'll speak with Dr. Roberto Pereira, research scientist in urban entomology at the University of Florida, about traumatic insemination in bed bugs.